Cresswell Kathrin, Cunningham-Burley Sarah, Sheikh Aziz
Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh.
.
J Innov Health Inform. 2017 Jan 25;23(4):882. doi: 10.14236/jhi.v23i4.882.
The United Kingdom (UK) lags behind other high-income countries in relation to technological innovation in healthcare. In order to inform UK strategy on how to catalyse innovation, we sought to understand what national strategies can help to promote a climate for innovation in healthcare settings by extracting lessons for the UK from international innovators.
We undertook a series of qualitative semi-structured interviews with senior international innovators from a range of health related policy, care/service delivery, commercial and academic backgrounds. Thematic analysis helped to explore how different stakeholder groups could facilitate/inhibit innovation at individual, organisational, and wider societal levels.
We conducted 14 interviews and found that a conducive climate for healthcare innovation comprised of national/regional strategies stimulating commercial competition, promoting public/private relationships, and providing central direction (e.g. incentives for adoption and regulation through standards) without being restrictive. Organisational attitudes with a willingness to experiment and to take risks were also seen as important, but a bottom-up approach to innovation, based on the identification of clinical need, was seen as a crucial first step to construct relevant national policies.
There is now a need to create mechanisms through which frontline National Health Service staff in relation can raise ideas/concerns and suggest opportunities for improvement, and then build national innovation environments that seek to address these needs. This should be accompanied by creating competitive health technology markets to stimulate a commercial environment that attracts high-quality health information technology experts and innovators working in partnership with staff and patients.
在医疗保健技术创新方面,英国落后于其他高收入国家。为了为英国制定促进创新的战略提供参考,我们试图通过借鉴国际创新者的经验教训,了解哪些国家战略有助于营造医疗保健领域的创新氛围。
我们对一系列来自与健康相关的政策、护理/服务提供、商业和学术背景的资深国际创新者进行了一系列定性半结构化访谈。主题分析有助于探讨不同利益相关者群体如何在个人、组织和更广泛的社会层面促进/抑制创新。
我们进行了14次访谈,发现有利于医疗保健创新的氛围包括国家/地区战略,这些战略刺激商业竞争、促进公私关系,并提供核心指导(例如通过标准进行采用激励和监管),同时又不过于严格。愿意尝试和冒险的组织态度也被视为很重要,但基于确定临床需求的自下而上的创新方法被视为构建相关国家政策的关键第一步。
现在需要建立机制,让一线国民保健服务人员能够提出想法/担忧,并提出改进机会,然后构建旨在满足这些需求的国家创新环境。与此同时,应创建具有竞争力的健康技术市场,以刺激商业环境,吸引与工作人员和患者合作的高质量健康信息技术专家和创新者。